Back | Next |
home / stock / mdwd / mdwd message board
Subject | By | Source | When |
---|---|---|---|
MediWound Ltd. (NASDAQ:$ MDWD) Can Raise Stock 5.20% More | midastouch017 | investorshub | 01/17/2023 10:34:22 AM |
PowerPoint Presentation Jan 2023. | midastouch017 | investorshub | 01/15/2023 4:13:51 PM |
Buy These 2 Stocks Before They Jump Over | midastouch017 | investorshub | 01/13/2023 3:55:57 PM |
vericel has a product called epicel for burn care. | realfast95 | investorshub | 01/10/2023 7:55:50 PM |
.....and Burn Care net revenue for full-year 2022 expected | midastouch017 | investorshub | 01/10/2023 4:39:18 PM |
From Vericel's preliminary results announced this morning | realfast95 | investorshub | 01/10/2023 3:58:26 PM |
MediWound: Gaining Traction | midastouch017 | investorshub | 01/08/2023 4:15:31 PM |
HC Wainwright Sets MediWound FY2027 Earnings Estimates at | realfast95 | investorshub | 01/06/2023 2:26:18 PM |
Total Addressable Market (TAM) for USA | realfast95 | investorshub | 01/06/2023 2:00:21 PM |
https://www.stockilluminati.com/mdwd/display.php?url=https%3a%2f%2fwww.stockilluminati.com%2fmdwd%2f | midastouch017 | investorshub | 01/05/2023 5:20:59 AM |
Vericel scores FDA approval for $142M burn treatment | midastouch017 | investorshub | 01/03/2023 4:02:29 PM |
Cowen & Co. Maintains Outperform on MediWound, Adjusts | realfast95 | investorshub | 12/30/2022 5:28:05 PM |
Depending when you sold out, seems | midastouch017 | investorshub | 12/30/2022 5:15:51 PM |
Great news. Congrats to those who were able | realfast95 | investorshub | 12/30/2022 5:12:05 PM |
FDA Approves MediWound's NexoBrid For Burn Treatment | midastouch017 | investorshub | 12/30/2022 1:08:44 PM |
I do not think revenues will pour in immediately | midastouch017 | investorshub | 12/30/2022 5:51:58 AM |
LOL, FDA approval, a $7.5 million milestone | midastouch017 | investorshub | 12/29/2022 7:25:34 PM |
MediWound Announces FDA Approval of NexoBrid for the | midastouch017 | investorshub | 12/29/2022 7:15:52 PM |
MediWound ($MDWD) Announces FDA Approval of NexoBrid for | midastouch017 | investorshub | 12/29/2022 6:58:45 PM |
$MDWD article in Hebrew Goog translated: | midastouch017 | investorshub | 12/29/2022 1:43:17 PM |
News, Short Squeeze, Breakout and More Instantly...
Funds to be used for clinical development of EscharEx ® to treat diabetic foot ulcers (DFUs) Award advances MediWound’s DFU program and its future revenues four years ahead of original schedule YAVNE, Israel, July 16, 2024 (GLOBE NEWSWIRE) -- MediWound Ltd....
Mölnlycke® Health Care announces US $15m investment in next-generation enzymatic therapeutics company MediWound Ltd PR Newswire GOTHENBURG, Sweden , July 15, 2024 /PRNewswire/ -- Mölnlycke Health Care, a world-leading MedTech company specialising i...
YAVNE, Israel, July 15, 2024 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), the world leader in next-generation enzymatic therapeutics for tissue repair, today announced it has entered into a definitive share purchase agreement with several new and existing investors, including Mölnlycke...